Ameritas Investment Partners, Inc. - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$448,000
+58.9%
4,824
+2.0%
0.02%
+50.0%
Q3 2021$282,000
-12.7%
4,7290.0%0.01%
-16.7%
Q2 2021$323,000
-1.5%
4,7290.0%0.01%
-7.7%
Q1 2021$328,000
-12.3%
4,729
-2.9%
0.01%
-23.5%
Q4 2020$374,000
+1.9%
4,870
-0.7%
0.02%0.0%
Q3 2020$367,000
+18.8%
4,9050.0%0.02%
+13.3%
Q2 2020$309,000
+62.6%
4,905
+8.4%
0.02%
+36.4%
Q1 2020$190,000
-4.5%
4,525
+3.1%
0.01%
+22.2%
Q4 2019$199,000
+5.3%
4,389
+6.0%
0.01%0.0%
Q3 2019$189,000
-22.2%
4,1390.0%0.01%
-18.2%
Q2 2019$243,000
+30.6%
4,1390.0%0.01%
+22.2%
Q1 2019$186,000
+15.5%
4,1390.0%0.01%0.0%
Q4 2018$161,000
-15.3%
4,1390.0%0.01%0.0%
Q3 2018$190,000
+5.6%
4,1390.0%0.01%0.0%
Q2 2018$180,000
+11.8%
4,139
+1.4%
0.01%
+12.5%
Q1 2018$161,000
+41.2%
4,080
+21.8%
0.01%
+60.0%
Q4 2017$114,000
+93.2%
3,350
+29.4%
0.01%
+66.7%
Q3 2017$59,000
+34.1%
2,5880.0%0.00%
+50.0%
Q2 2017$44,0002,5880.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 163,133$7,467,0004.14%
PFM Health Sciences, LP 2,271,536$103,968,0003.07%
Partner Investment Management, L.P. 28,877$1,322,0002.26%
Atika Capital Management LLC 181,000$8,284,0001.74%
DAFNA Capital Management LLC 93,942$4,300,0001.62%
Asymmetry Capital Management, L.P. 16,272$745,0001.60%
First Light Asset Management, LLC 190,838$8,735,0001.32%
Perceptive Advisors 953,129$43,624,0001.18%
Rhenman & Partners Asset Management AB 155,000$7,094,0000.89%
Opus Point Partners Management, LLC 9,770$447,0000.81%
View complete list of ARENA PHARMACEUTICALS INC shareholders